Checking thinking skills after CAR-T therapy
Part of Blood & lymphatic, Brain & nervous system, Cancer clinical trials.
This study uses a simple iPad test to check for thinking problems that can happen after CAR-T cell therapy. It aims to catch these issues early so they can be managed better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received CAR-T cell therapy
- You are 18 years or older
- You are not pregnant
- You are willing to use an iPad for the test
- You have vision good enough to see the iPad screen (20/100 or better)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses blood tests and brain imaging to better understand and predict nerve-system side effects that can happen after CAR T-cell treatment. It may help doctors spot people at higher risk sooner and guide safer care.
This study is for people getting CAR-T cell therapy, a type of cancer treatment that uses your own immune cells. Researchers want to understand a rare side effect called neurotoxicity by looking at tiny particles in your blood called extracellular vesicles.
This study tests if checking your pupil size with a small light device can predict brain-related side effects from CAR-T cell therapy. It is for patients with certain lymphomas receiving axi-cel CAR-T treatment in the hospital.
This study checks how well you can think, remember, and make decisions during a type of cancer treatment called CAR T-cell therapy, and whether these abilities change over time.
This study watches patients getting CAR-T cell therapy to see if it affects brain function, thinking, or memory. It aims to find out how common these effects are and help doctors manage them.
This study looks at how a special type of immunotherapy called CAR-T therapy might affect your thinking skills, memory, and ability to focus. By checking on patients early and often, the team hopes to find simple ways to detect and manage these side effects sooner.
Hear when a new Neurotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.